HYPROMELLOSES
Unresolved Excipient
Suggest One
No specific molecular structure known for this excipient.
- CAS
- 9004653
- UNII
- 3NXW29V3WO
- SYNONYMS
-
- ZINC ID(s)
-
- Availability
- Present in 0 ZINC catalogs
Known Active Genes
There has not been any activity reported at 10μM or less for this excipient (per ChEBML)
Clinical Trials
This compound has not been in (or located in) any clinical trials (per clinicaltrials.gov).
(Browse) Purchasable Analogs in ZINC
Analogs cannot be located as there is no structure provided for this compound. Try a
search by name.
Dosages
| Route | Formulation | Per Unit Dose |
|---|---|---|
| Buccal | Tablet | 24MG |
| Nasal | Spray | 0.1% |
| Nasal | Spray, Metered | 0.1%W/V |
| Ophthalmic | Gel | 2.25% |
| Ophthalmic | Solution | 50% |
| Ophthalmic | Solution, Drops | 0.25% |
| Ophthalmic | Solution/drops | 0.5% |
| Ophthalmic | Suspension | 0.5% |
| Ophthalmic | Suspension, Drops | 0.6% |
| Oral | Capsule | 150MG |
| Oral | Capsule, Coated Pellets | 3.32MG |
| Oral | Capsule, Delayed Action | 64.47MG |
| Oral | Capsule, Delayed Action, Coated, Hard Gelatin | 20MG |
| Oral | Capsule, Delayed Action, Enteric Coated | |
| Oral | Capsule, Delayed Action, Enteric Coated, Hard Gelatin | 96MG |
| Oral | Capsule, Enteric Coated Pellets | 39.66MG |
| Oral | Capsule, Extended Release | 117MG |
| Oral | Capsule, Hard Gelatin | 73.9MG |
| Oral | Capsule, Soft Gelatin Liquid-Filled | 118MG |
| Oral | Capsule, Sustained Action | 100.4MG |
| Oral | Capsule, Sustained Action | 670.04MG |
| Oral | Concentrate | |
| Oral | Drops | 0.13% |
| Oral | Film, Soluble | 33.5MG |
| Oral | Granule, Enteric Coated | 17.2MG |
| Oral | Granule, For Oral Suspension | 10.6MG |
| Oral | Pellet | 6.7MG |
| Oral | Powder, For Oral Suspension | 1.5% |
| Oral | Powder, For Reconstitution | 3% |
| Oral | Powder, For Suspension | 1.3% |
| Oral | Solution | 0.45% |
| Oral | Suspension | 0.4% |
| Oral | Suspension | 6.5% |
| Oral | Suspension, Liquid | 0.5% |
| Oral | Syrup | 3.6% |
| Oral | Tablet | 2.4MG |
| Oral | Tablet (Immed./comp. Release), Coated | 19.2MG |
| Oral | Tablet (Immed./comp. Release), Film Coated | 16MG |
| Oral | Tablet (Immed./comp. Release), Uncoated, Chewable | 10MG |
| Oral | Tablet, Chewable | 22MG |
| Oral | Tablet, Coated | 245MG |
| Oral | Tablet, Controlled Release | 31.25MG |
| Oral | Tablet, Controlled Release | 65.7MG |
| Oral | Tablet, Delayed Action | 16.65MG |
| Oral | Tablet, Delayed Action, Enteric Coated | 127.29MG |
| Oral | Tablet, Extended Release | 400MG |
| Oral | Tablet, Film Coated | 536.8MG |
| Oral | Tablet, Film Coated, Extended Release | 9.91MG |
| Oral | Tablet, For Suspension | 45MG |
| Oral | Tablet, Multilayer, Extended Release | 8.4MG |
| Oral | Tablet, Orally Disintegrating | 18MG |
| Oral | Tablet, Sustained Action | 15.97MG |
| Oral | Tablet, Sustained Action | 400MG |
| Oral | Tablet, Sustained Action, Coated | 221MG |
| Oral | Tablet, Sustained Action, Film Coated | 58.33MG |
| Oral | Tablet, Sustained Release, Film Coated | 300MG |
| Oral-21 | Tablet | 8MG |
| Oral-21 | Tablet, Coated | 8MG |
| Oral-28 | Tablet | 8MG |
| Oral-28 | Tablet, Coated | 8MG |
| Rectal | Gel | 8.7% |
| Topical | Emulsion, Cream | 0.1% |
| Topical | Emulsion, Lotion | 0.1% |
| Topical | Jelly | 2.5% |
| Topical | Lotion | 0.1% |
| Topical | Patch | |
| Topical | Solution | 0.5% |
| Topical | Solution, Drops | 0.11%W/V |
| Urethral | Jelly | 2.3% |
| Vaginal | Gel | 3.5% |
| Vaginal | Insert | 52.6MG |
| Vaginal | Tablet | 5MG |
| Vaginal | Tablet, Film Coated | 54.21MG |